CTRI/2021/10/037159尚未招募4 期
Immunogenicity, molecular profiling and safety of a marketed Quadrivalent Influenza Vaccine (FluQuadri TM )administered by the intramuscular route in children 3-8 years old - INCENTIVE: QIV-2
Seth GS Medical College KEM Hospital0 个研究点目标入组 0 人开始时间: 待定最近更新:
试验速览
- 阶段
- 4 期
- 状态
- 尚未招募
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1.Healthy children or children with well controlled pre-existing medical conditions (as concluded from the medical history, physical examination and clinical judgement) age range >=3 and <=9 years old on the day of the study
- •2. Written, informed consent from parents/guardians.
- •3. Oral assent for 7-8 years of aged children.
- •4. Parents/Guardians able to understand and comply with the study protocol requirements, including availability for all scheduled visits of the study.
排除标准
- 未提供
研究者
相似试验
尚未招募
4 期
Immunity against Influenza virus disease and safety of FluQuadri (marketed vaccine with protection against 4 types of influenza virus) in children of age between 6 and 12 monthsCTRI/2021/10/037161Seth GS Medical College and KEM Hospital
进行中（未招募）
1 期
Immunogenicity, molecular profiling and safety of a marketed quadrivalent influenza vaccine (Vaxigrip Tetra) administered by the intramuscular route in children 3-11 years oldImmune response to infuenza vaccine in young childrenEUCTR2021-003804-42-NOHelse Bergen HF50
已完成
4 期
Immunity against Influenza virus disease and safety of FluQuadri (marketed vaccine with protection against 4 types of influenza virus) in participants 60 years of age and olderCTRI/2020/09/027913Seth GSMC and KEM Hospital100
进行中（未招募）
1 期
Immunity to influenza virus disease and safety of Vaxigrip Tetra® (commercial vaccine with protection against 4 types of influenza virus) in participants 60 years and olderInfluenzaEUCTR2021-003307-18-BEniversity of Antwerp50
已完成
1 期
Investigating of the Immunogenicity and Safety of Lactococcus Lactis Vaccine Related to Human Papillomavirus Type 16IRCT20190504043464N1Iran University of Medical Sciences200